Belyaeva et al., 2022 - Google Patents
Development and testing of a vaccine against infectious atrophic rhinitis and pasteurellosis in pigsBelyaeva et al., 2022
View PDF- Document ID
- 14475491415191221651
- Author
- Belyaeva A
- Kapustin A
- Shastin P
- Ivanov E
- Laishevtsev A
- Publication year
- Publication venue
- BIO Web of Conferences
External Links
Snippet
This work presents the results of the development and testing of a domestic vaccine against infectious atrophic rhinitis and pasteurellosis in pigs caused by Bordetella bronchiseptica and Pasteurella multocida type A and D. A drug was designed with the following antigenic …
- 229960005486 vaccines 0 title abstract description 25
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA121193C2 (en) | Method of making a mycoplasma vaccine | |
| US9783788B2 (en) | Porcine pseudorabies virus (PRV)-YF strain and its application | |
| RU2429012C1 (en) | Method of manufacturing associated vaccine against colibacteriosis, streptococcosis and enterococcal infection of calves and piglets | |
| CN117844686A (en) | Separation, identification and application of avibacterium paragallinarum serum A strain with cross protection effect | |
| Belyaeva et al. | Development and testing of a vaccine against infectious atrophic rhinitis and pasteurellosis in pigs | |
| RU2687488C1 (en) | Poly-strain formolated vaccine against calves pneumonia streptococcal etiology | |
| RU2377014C1 (en) | Method for production of staphylococcic anatoxin-vaccine | |
| RU2432174C1 (en) | Method for producing colibacillosis anatoxin | |
| RU2377015C1 (en) | Vaccine inactivated against salmonellosis of doves and method of its application | |
| RU2761379C1 (en) | Polyvalent inactivated vaccine against swine streptococcosis, method for its production and use | |
| Derevyanko et al. | Preclinical and clinical trials of a new Ukrainian inactivated vaccine against actinobacillary pleuropneumonia in pigs | |
| RU2406531C1 (en) | Associated vaccine against streptoccocosis, pseudomonosis and enterococcus infection in nutria | |
| CN113018426B (en) | Combined strain for preparing haemophilus parasuis vaccine, octavalent inactivated vaccine and application thereof | |
| CN111154678B (en) | Horse abortion salmonella donkey source strain and application thereof in preparation of donkey paratyphoid inactivated vaccine | |
| RU2316344C1 (en) | Associated vaccine against colibacteriosis, salmonellosis, streptococcosis and enterococcal infection in nutrias | |
| RU2296583C1 (en) | Vaccine, associated against nutria salmonellosis and enterococcus infection | |
| RU2544951C1 (en) | ATTENUATED STRAIN Bacillus anthracis FOR DEVELOPING MEANS OF SPECIFIC PREVENTION OF ANTHRAX | |
| RU2531054C1 (en) | Associated pseudomonosis and rabbit viral haemorrhagic disease vaccine | |
| RU2750865C1 (en) | Polyvalent inactivated vaccine against riemerellosis, pasteurellosis and salmonellosis of turkeys, ducks and geese, the method of its preparation | |
| RU2406533C1 (en) | Associated vaccine against streptococcosis and staphylococcosis of cattle | |
| CN112694988B (en) | Chicken source streptococcus suis attenuated strain and application thereof | |
| UA117089U (en) | SITC Vaccine Inactivated for Specific Prevention of Streptococcal, Enterococcal and Staphylococcal Etiology | |
| Nikolai et al. | A comprehensive study of the effect of the new generation vaccine against Gumboro disease on the immune status of broilers cross Ross-308 | |
| RU2540144C1 (en) | METHOD FOR OBTAINING ANATOXIN Bordetella pertussis | |
| Abdusattarov et al. | Ways to increase the effectiveness of hyperimmune serum against colibacteriosis, salmonellosis and pasteureellosis of lambs |